Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 18

Berkshire Grey picks reverse merger route

SoftBank’s robotics portfolio company Berkshire Grey has lined up a reverse merger with Revolution Acceleration Acquisition Corp and will be valued at $2.7bn.

Feb 25, 2021

ReNew Power charges towards Nasdaq

Having abandoned plans for an IPO three years ago, ReNew Power has now settled on a reverse merger and will secure proceeds worth $1.2bn.

Feb 25, 2021

Joby Aviation takes flight for reverse merger

The Intel Capital, JetBlue Technology Ventures, Toyota AI Ventures and Uber-backed flying car developer is set to list on the NYSE.

Feb 25, 2021

WingArc1st to fly to public markets

The business software producer is set to float in a $172m offering on TSE that will enable Data Applications, Itochu, Pksha, Sansan, Suzuyo, SystemExe, Teikoku DataBank and Toshiba Digital Solutions to exit.

Feb 24, 2021

Humacyte hooks into Alpha Healthcare

Fresenius Medical Care and Access Industries-backed Humacyte will merge with Alpha Healthcare Acquisition Corp to become a public business with a market cap of $1.1bn.

Feb 19, 2021

AEye identifies reverse merger opportunity

Aisin, Airbus, Intel, LG, SBI, Hella and SK Hynix all celebrated a win as AEye agreed to a reverse merger with CF Finance to list on Nasdaq at a $2bn valuation.

Feb 18, 2021

Cloopen completes $320m IPO

Cloopen, also known as Ronglian and Yuntongxun, priced its shares at $16 to raise $320m in an initial public offering that provided an exit for Telstra Ventures and New Oriental.

Feb 17, 2021

Adagene advances to IPO

WuXi AppTec and New World Development-backed Adagene has raised close to $140m in its initial public offering after having secured $155m in equity financing.

Feb 17, 2021

Owlet grows into public company

Amazon-backed Owlet Baby Care has agreed to a reverse merger with special purpose acquisition company Sandbridge for a post-deal valuation of $1.39bn.

Feb 17, 2021

Decibel resonates with public markets

The hearing loss treatment developer has raised more than $127m in its initial public offering that offered exits to Alphabet, GlaxoSmithKline and Regeneron.

Feb 15, 2021

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here